Ty Vincent, MD





ABOUT DR. VINCENT:
Ty Vincent, MD is an integrative physician in practice since 2005 in Wasilla, Alaska where he has a large multidisciplinary integrative clinic. He completed medical school through the University of Washington, and a residency in family medicine in Anchorage, Alaska. Dr. Vincent has gained additional training in acupuncture, Chinese medicine, environmental medicine, allergy and immunology, bio-identical hormone therapy, chelation therapy, hyperbaric medicine, integrative cancer therapy, Reiki and nutritional medicine.

Dr. Vincent has lectured nationally many times on the subjects of bio-identical hormone therapies, vitamin D, and low dose immunotherapy. In 2014, Dr. Vincent developed immune therapy techniques for treating chronic Lyme disease and a large number of autoimmune diseases with a high degree of success and safety. He has since been treating patients across the country with these disabling illnesses, and educating other practitioners in the use of this new therapy.

Dr. Vincent is married with eight children, and currently resides in Kona, Hawaii. He works from home, helping chronically ill people around the world via telemedicine consultation and sending Low Dose Immunotherapy to their homes. He can be best reached via email at customerservice@globalimmunotherapy.com. The website www.globalimmunotherapy.com has more information for providers and patients.

DISCLOSURE STATEMENT
Dr. Vincent has indicated that he has no financial relationships with any commercial supporters.

LOW DOSE IMMUNOTHERAPY 2 Day Workshop- 11.75 CME Credits
Wednesday, November 7: 8AM - 5PM; Thursday, November 8: 8AM - 1:30PM
$699 (not included in conference registration)   VIEW WORKSHOP SCHEDULE  
ABOUT THE WORKSHOP:
Low Dose Immunotherapy (LDI) is a remarkable treatment for allergies, most types and autoimmune disease and various chronic inflammatory disorders. The technique originated around 1960, as Enzyme-Potentiated Desensitization, changed to Low Dose Allergy (LDA) therapy in the 1990's in the U.S., and has an excellent record of success with allergic conditions such as asthma, hay fever, chronic rhinitis/sinusitis, severe eczema, urticaria, anaphylaxis foods, chemical sensitivities and inhalant allergy of all types. More recently, through the work of Dr. Vincent, it has been found to be an extremely effective new treatment for Lyme disease and a growing number of immune-mediated and inflammatory conditions. There are now nearly 200 practitioners in the LDI network internationally, including MD/DO physicians, ANP's, PA's, naturopaths and other integrative practitioners. Practitioners who employ LDA feel there is no better immunotherapy technique available anywhere, especially for difficult and complex immune/inflammatory problems.

This two-day workshop on LDI instruction will include basic instruction for qualified personnel who want to begin using the technique the right way, basic dosage strategies, and all that is needed to use this treatment. No previous experience with homeopathy or other forms of immunotherapy is required. Instruction will begin with the history of the technique, basic concepts and proposed mechanisms, and progress through new clinical developments to the nuts and bolts of practical application of the technique. There will be ample time for Q&A; and practitioners should leave with the training needed to begin utilizing this therapy right away.

The more advanced treatment methods for a growing number of autoimmune and inflammatory illnesses with LDI are truly remarkable, and are based on the principal of “molecular mimicry”. Understanding this principal permits us to treat autoimmune illnesses that are typically precipitated by the body’s untoward reaction to bacteria and other organisms that live within us. Practitioners using LDI are successfully treating rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn’s disease, Lyme disease, multiple sclerosis, interstitial cystitis, psoriasis and other severe afflictions that are typically treated without powerful and potentially hazardous medications.

One of the most exciting recent developments is the LDI treatment for Lyme disease that Dr. Vincent discovered in 2014 and that most LDI practitioners are now using successfully. LDI eliminates the need for antibiotics or antimicrobial treatments of any sort, and has much greater success. Dr. Vincent will tell you all about the advances in technique he has discovered to more rapidly find the precise treatment dose.

Mastering this technique will quickly make you the most sought-after practitioner in your area, known for treating “impossible” conditions with dramatic success. Whether you are a prospective user of LDA/LDI or one who has used it for many years, you will leave this meeting with knowledge far beyond your expectations and with new treatments you can employ immediately.

 

A NEW EPIDEMIC: TESTOSTERONE DEFICIENCY IN YOUNG MEN: 
Friday, November 9: 1:15 PM - 2:00 PM  

ABOUT THE LECTURE:
Hypogonadism, or testosterone deficiency, has long been thought to only affect older men. This lecture will present research and practitioner experience to demonstrate that men aged 18 to 40 are perhaps at far greater risk for this problem in the new era. Young men to not present the same as older men, and frequently go undiagnosed. The differences will be discussed, as well as a suggested diagnostic approach. Environmental causes for this condition will be discussed, with published scientific data as support. A clinical approach to treatment and testosterone replacement therapy will be presented, with case examples as illustration.

 

LOW DOSE IMMUNOTHERAPY FOR CHRONIC "INFECTIONS": 
Saturday, November 10: 10:10 AM - 11:10 AM 
ABOUT THE LECTURE:
Some chronic conditions are thought to be "infections" when they are actually something quite different. This lecture will discuss the important distinction between a true infection and a chronic immune-mediated inflammatory condition. Examples used to illustrate this concept will include Lyme disease, Chronic Fatigue Syndrome, Fibromyalgia, Acne, Genital Herpes and others. The treatment approach to chronic immune-mediated disorders should not be based on antimicrobial therapies. Low Dose Immunotherapy (LDI) is a fairly new treatment technique for chronic inflammatory conditions that can dramatically improve these conditions through immune modulation rather than antimicrobial strategies. Case examples will be used to illustrate this.
 
 

NEED ASSISTANCE REGISTERING? A Meeting by Design
1.888.995.3088  |  info@ameetingbydesign.com

ACAM HEADQUARTERS: 
1.800.532.3688  |  info@acam.org  |  www.acam.org